SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
______________
Date of Report (Date of earliest event reported): MAY 22, 2001
ORCHID BIOSCIENCES, INC.
(Exact name of registrant as specified in its charter)
Delaware 000-30267 22-3392819
- ------------------ --------------------- ---------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
303 COLLEGE ROAD EAST
Princeton, NJ 08540
---------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (609) 750-2200
--------------
None
-------------------------------------------------------------
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS.
On May 22, 2001, the Registrant publicly disseminated a press release
announcing that the Board of Director's of the Registrant adopted a Stockholder
Rights Plan to protect its stockholders. The information contained in the press
release is incorporated herein by reference and filed as Exhibit 99.1 hereto.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
99.1 The Registrant's Press Release dated May 22, 2001.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Orchid BioSciences, Inc.
Date: May 22, 2001 /s/ Donald R. Marvin
---------------------------------
Donald R. Marvin
SENIOR VICE PRESIDENT, CHIEF OPERATING
OFFICER, CHIEF FINANCIAL OFFICER
EXHIBIT INDEX
-------------
Exhibit
Number Description
- ------- -----------
99.1 The Registrant's Press Release
dated May 22, 2001.